Ranirestat for the Management of Diabetic Sensorimotor Polyneuropathy

OBJECTIVE: Aldose reductase inhibitors (ARIs) are potential disease modifiers for diabetes complications. We aimed to determine whether ranirestat, an ARI, could slow or reverse the course of diabetic sensorimotor polyneuropathy (DSP). RESEARCH DESIGN AND METHODS: A total of 549 patients with DSP we...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Bril, Vera, Hirose, Toshiyuki, Tomioka, Sasagu, Buchanan, Robert
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Diabetes Association 2009
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2699746/
https://ncbi.nlm.nih.gov/pubmed/19366965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc08-2110
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia